The same cannot be said for under-the-radar biotech leader Repligen (RGEN) – Get Repligen Corporation Report. The $13 billion company develops, manufactures, and sells equipment required to … https://www.msn.com/en-us/finance/companies/this-biotech-leader-cant-stop-growing/ar-AA10g6Ar